Integrating Flow Cytometry in the Diagnostic Work of <scp>HIV</scp> ‐Associated Hodgkin's Lymphomas
Hodgkin lymphoma (HL) is prevalent worldwide and typically presents symptoms like sudden pain, swelling, and weight loss. Classical HL (cHL) is largely treatable with modern risk-adapted and response-based therapy. cHL represents one of the most common malignancies occurring during the course of evolution in patients living with HIV. The present manuscript aimed to present the diagnostic work-up with an emphasis on flow cytometry in patients with HIV-associated lymphoma, of important clinical benefit both in the HIV-endemic setting as well as in state-of-the-art pathology departments. Three clinical cases of HIV patients, including HIV-associated cHL, are presented in the chapter dedicated to HIV-induced lymphomas diagnosed by FC, as Supporting Information, to support the particularities of the abundance of clonal B-cell populations among different types of HIV-related lymphomas. This adds to the proof-of-concept that the specific antibody panel design may help practitioners in discriminating among similar subtypes of HIV-associated lymphomas. Recent data emphasise the importance of FC detection of cHL rapidly and effectively, adding diagnostic value to these small biopsies. FC is an important tool for clinical decision-making in the management of HL patients, providing a noninvasive and accurate biomarker evaluation. For these considerations, we can conclude that FC is a very useful research tool, and the clinical cases presented in this paper indicate their importance in the rapid diagnosis of cHL as well.
Authors
- Diana Cenariu (ORCID: https://orcid.org/0000-0002-1024-1479)
- Ioana Rus
- Khalid Abdelrahman (ORCID: https://orcid.org/0000-0003-0576-6120)
- Diana Gulei (ORCID: https://orcid.org/0000-0002-3030-8626)
- Horia Bumbea (ORCID: https://orcid.org/0000-0002-3706-3166)
- Bogdan Fetică (ORCID: https://orcid.org/0000-0001-8640-7546)
- Dávid Kegyes (ORCID: https://orcid.org/0000-0002-6252-6281)
- Marc Damian
- Victor Tomacinschii (ORCID: https://orcid.org/0000-0002-5907-1714)
- Mădălina Nistor (ORCID: https://orcid.org/0000-0002-5626-6911)
- Cristina Selicean (ORCID: https://orcid.org/0000-0002-6339-4663)
- Maria Santa
- Sanda Buruiana (ORCID: https://orcid.org/0000-0003-2341-0099)
- Cristina Stefan
- Ciprian Tomuleasa
- Anamaria Bancos
- Rand Bilal
- Adrian‐Bogdan Tigu
- Cristian Jinca
- Mihnea Zdrenghea
- Jonathan Fromm
- Andrew K. Ndlovu
- Tendani Gaolathe
- Patricia Rantshabeng
Institutions
- University of Botswana (BW)
- SingHealth (SG)
- Carol Davila University of Medicine and Pharmacy (RO)
- University of Washington (US)
- Iuliu Hațieganu University of Medicine and Pharmacy (RO)
- Clinical Emergency Hospital Bucharest (RO)
- Institute of Microbiology and Biotechnology (MD)
- SingHealth Duke-NUS Academic Medical Centre (SG)
- Emergency University (US)
- Institute of Oncology Prof. Dr. Ion Chiricuta (RO)
- Nicolae Testemițanu State University of Medicine and Pharmacy (MD)
- University of Global Health Equity (RW)
- Botswana Harvard AIDS Institute Partnership (BW)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- Journal of Cellular and Molecular Medicine
- Published
- 2026-05-01
- DOI
- https://doi.org/10.1111/jcmm.71143
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission
- Universitatea de Medicină şi Farmacie Iuliu Haţieganu Cluj-Napoca